This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

PD-L1: A potential treatment target for multiple sclerosis

March 12th, 2014

Experimental allergic encephalomyelitis is a mouse model of human multiple sclerosis with similar pathology and pathogenesis. Th1 cells play an important role in the pathogenesis of experimental allergic encephalomyelitis. Therefore, Qun Xue, Fanli Dong and co-workers from the First Affiliated Hospital of Soochow University in China speculated that programmed cell death 1 ligand 1 (PD-L1) plays an important role in the pathogenesis of multiple sclerosis.

A recent study by these researchers published in the Neural Regeneration Research (Vol. 8, No. 35, 2013) found that the expression of PD-L1 in the spinal cord and splenocytes of mice with experimental allergic encephalomyelitis was significantly increased compared with normal mice. This evidence provides the basement for exploring the role of PD-L1 in multiple sclerosis.

More information:
Li M, Jiang JD, Fu B, Chen JC, Xue Q, Dong WL, Gu YZ, Tang LT, Xue LM, Fang Q, Wang MY, Zhang XG. PD-L1 is increased in the spinal cord and infiltrating lymphocytes in experimental allergic encephalomyelitis. Neural Regen Res. 2013;8(35):3296-3305.

Provided by Neural Regeneration Research

Citation: PD-L1: A potential treatment target for multiple sclerosis (2014, March 12) retrieved 26 July 2026 from https://sciencex.com/wire-news/156071668/pd-l1-a-potential-treatment-target-for-multiple-sclerosis.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.